Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Gottardo

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Infectious Diseases|February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Journal of Virology|October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Scientific Reports|February 11, 2016
Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping ConsortiumGreg Finak, Marc Langweiler, Maria Jaimes, et al.
Journal of Virology|February 12, 2016
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensBenedikt Asbach, Alexander Kliche, Josef Köstler, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Journal of Virology|October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Scientific Reports|February 11, 2016
Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping ConsortiumGreg Finak, Marc Langweiler, Maria Jaimes, et al.
Journal of Virology|February 12, 2016
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensBenedikt Asbach, Alexander Kliche, Josef Köstler, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Pageof 19